Howe & Rusling Inc Castle Biosciences Inc Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $1,035 - $1,578	46 Added 54.12%	131 $3,000
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $960 - $2,759	60 Added 240.0%	85 $2,000
Q1 2022 May 10, 2022	SELL	$33.17 - $46.98 $265 - $375	-8 Reduced 24.24%	25 $1,000
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $541 - $698	9 Added 37.5%	33 $2,000
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $1,201 - $1,842	24 New	24 $2,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $458M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.